- Drug Delivery
- Capsule Endoscopy
- Patient Monitoring
Smart Pills Market size was valued at USD 301 million in 2023 and is expected to reach USD 704 million by 2030 and grow at a CAGR of 14.2% from 2024 to 2030. Smart pills are injectable medical devices taken orally to examine the gastrointestinal tract. The advanced smart pills enable disease diagnosis, and patient monitoring, and help to improve drug delivery. Cameras, trackers, and sensors are commonly used smart pills swallowed by patients to get complete GI evaluation without surgery. Smart pills are expected to replace conventional diagnostic techniques such as colonoscopy and endoscopy. An increase in the geriatric population coupled with a rise in preference for minimally invasive surgical procedures is anticipated to drive the global smart pills market. Moreover, technological advancements in smart pills, a rise in the prevalence of GI disorders, sophisticated healthcare infrastructure, wide applications with smart pills, and a rise in disposable income are anticipated to fuel the global market over the forecast period. However, the high cost of products, technological constraints the efficiency of capsule endoscopes, and patients' fear regarding smart pill swallowing are expected to dampen the growth of the market. Capsule endoscopy, for example, was developed in response to a high demand for minimally invasive surgical treatments. Capsule endoscopy is projected to replace traditional endoscopic methods due to advantages such as ease of administration and thorough monitoring of the gastrointestinal tract.
Smart Pills Market Key Developments
- In November 2017, Otsuka America Pharmaceutical, Inc. received FDA approval for Abilify MyCite, (Aripiprazole tablets with sensor)
Smart Pills Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
14.2%
Largest Market
North America
Fastest Growing Market
Europe
Smart Pills Market Dynamics
The rise in the prevalence of lifestyle-related conditions such as obesity, gastroesophageal reflux disease (GERD), stomach ulcers, and others, as well as a significant increase in the senior population, all contribute to the expansion of the smart pill market. Increased R&D investments in the development of smart pills will also help the industry flourish. However, strict government rules regulating the rising usage of these devices, as well as the expensive cost of ingestible sensors, are expected to limit the market's growth. Furthermore, improvements in smart pill technology, such as bioelectronics, microprocessors, micro-cameras, miniaturisation, and others, are expected to create lucrative prospects in the future.
North-America Got Significant Share
Smart Pills Market Regional Analysis
Geographically, global smart pills market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America smart pills market has a lucrative share attributed to increase in the prevalence of GI disorders due to change in lifestyle, innovation of newer smart pills by market players, and favorable reimbursement policies are fuel the market. Europe smart pills market is poised to grow at a notable CAGR due to adoption of technologically advanced smart pills, rise in government investment in healthcare sector, and well established healthcare infrastructure. Asia Pacific smart pills market has a lucrative growth owing to large patient pool with GI disorders, increase in healthcare expenditure, and entry of market players into Asia Pacific region are fuel the market.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Smart Pills Market Segmentation
By Application
By Target Area
- Stomach
- Esophagus
- Large Intestine
- Small Intestine
By Distribution Channel
- Hospitals
- Clinics
- Research Institutes
Frequently Asked Questions
The smart pills market size was valued at USD 301 million in 2023
The smart pills market key players are: Medimetrics S.A. de C.V. (Mexico) CapsoVision, Inc. (U.S.) Bio-Images Research Limited (U.K.) Olympus Corporation (Japan) Given Imaging, Inc. (Israel) SmartPill Corporation (U.S.) Siemens Healthineers (U.S.) Medtronic plc (Ireland) Koninklijke Philips N.V. (Netherlands) GE Healthcare (U.S.) Otsuka America Pharmaceutical, Inc. (U.S.)
The smart pills market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Smart Pills Market Introduction |
| 2.1.Global Smart Pills Market - Taxonomy |
| 2.2.Global Smart Pills Market - Definitions |
| 2.2.1. By Application |
| 2.2.2. By Target Area |
| 2.2.3. By Distribution Channel |
| 2.2.4.Region |
| 3. Global Smart Pills Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Smart Pills Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Smart Pills Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Drug Delivery |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Capsule Endoscopy |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Patient Monitoring |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Smart Pills Market By Target Area, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Stomach |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Esophagus |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Large Intestine |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Small Intestine |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Smart Pills Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Clinics |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Research Institutes |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Smart Pills Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Smart Pills Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Drug Delivery |
| 9.1.2.Capsule Endoscopy |
| 9.1.3.Patient Monitoring |
| 9.2. Target Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Stomach |
| 9.2.2.Esophagus |
| 9.2.3.Large Intestine |
| 9.2.4.Small Intestine |
| 9.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Clinics |
| 9.3.3.Research Institutes |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Smart Pills Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Drug Delivery |
| 10.1.2.Capsule Endoscopy |
| 10.1.3.Patient Monitoring |
| 10.2. Target Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Stomach |
| 10.2.2.Esophagus |
| 10.2.3.Large Intestine |
| 10.2.4.Small Intestine |
| 10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Clinics |
| 10.3.3.Research Institutes |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Smart Pills Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Drug Delivery |
| 11.1.2.Capsule Endoscopy |
| 11.1.3.Patient Monitoring |
| 11.2. Target Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Stomach |
| 11.2.2.Esophagus |
| 11.2.3.Large Intestine |
| 11.2.4.Small Intestine |
| 11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Clinics |
| 11.3.3.Research Institutes |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Smart Pills Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Drug Delivery |
| 12.1.2.Capsule Endoscopy |
| 12.1.3.Patient Monitoring |
| 12.2. Target Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Stomach |
| 12.2.2.Esophagus |
| 12.2.3.Large Intestine |
| 12.2.4.Small Intestine |
| 12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Clinics |
| 12.3.3.Research Institutes |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Smart Pills Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Drug Delivery |
| 13.1.2.Capsule Endoscopy |
| 13.1.3.Patient Monitoring |
| 13.2. Target Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Stomach |
| 13.2.2.Esophagus |
| 13.2.3.Large Intestine |
| 13.2.4.Small Intestine |
| 13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Clinics |
| 13.3.3.Research Institutes |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M&A, Strategies, and SWOT Analysis) |
| 14.2.1.Medimetrics S.A. de C.V. (Mexico) |
| 14.2.2.CapsoVision, Inc. (U.S.) |
| 14.2.3.Bio-Images Research Limited (U.K.) |
| 14.2.4.Olympus Corporation (Japan) |
| 14.2.5.Given Imaging, Inc. (Israel) |
| 14.2.6.SmartPill Corporation (U.S.) |
| 14.2.7.Siemens Healthineers (U.S.) |
| 14.2.8.Medtronic plc (Ireland) |
| 14.2.9.Koninklijke Philips N.V. (Netherlands) |
| 14.2.10.GE Healthcare (U.S.) |
| 14.2.11.Otsuka America Pharmaceutical, Inc. (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Medimetrics S.A. de C.V. (Mexico)
- CapsoVision, Inc. (U.S.)
- Bio-Images Research Limited (U.K.)
- Olympus Corporation (Japan)
- Given Imaging, Inc. (Israel)
- SmartPill Corporation (U.S.)
- Siemens Healthineers (U.S.)
- Medtronic plc (Ireland)
- Koninklijke Philips N.V. (Netherlands)
- GE Healthcare (U.S.)
- Otsuka America Pharmaceutical, Inc. (U.S.)